Viatronix, Inc Announces The Appointment Of Jonah Aburrow-Jones As Its Director Of Business Development

STONY BROOK, N.Y., May 17 /PRNewswire/ -- Viatronix Incorporated -- a Stony Brook, New York-based industry leader in 2D/3D clinical solutions -- announces the appointment of Jonah Aburrow-Jones as its new Director of Business Development. Jonah will manage both the domestic U.S. market as well as the International market.

"We are pleased to have Jonah join our team at Viatronix," said Zaffar Hayat, President of Viatronix Incorporated. "He brings with him many years of industry experience in the imaging arena, with previous experience at EZEM, Voxar and, most recently, Medicsight, holding positions in product management and business development. We look forward to further strengthening our sales and distribution channels under the astute leadership of Jonah."

"Viatronix is a company renowned for innovative clinical applications for medical imaging and I am excited to be joining the team," said Jonah Aburrow-Jones. "Viatronix remains at the forefront of medical imaging software. Their commitment to developing new applications and giving access to these clinical tools integrated into PACS demonstrates their commitment to grow and become a larger player in 3D medical imaging. We will be driving growth for Viatronix through both partnerships and direct sales in the United States and internationally," he added.

About Viatronix

Viatronix is a leading innovator and developer of 2D/3D medical imaging and diagnostic software. Our software enables physicians to interactively view vital organs and anatomical structures within the human body from data acquired by standard medical imaging equipment in minimally or non-invasive methods. The 2D digital data acquired from imaging devices is automatically post processed using the company's proprietary software techniques and provides 3D diagnostic quality images for the physician. The company's first product, V3D-Colon for "virtual colonoscopy" allows physicians to interactively view the colon reconstructed from a CT scan, providing visualization of the inner surface that includes polyps and lesions. The company's V3D-Explorer offers a robust and user-friendly workstation platform that views and reconstructs data in 2D/3D for virtually any organ in the body. V3D-Calcium Scoring aids physicians in determining the amount of calcified plaque accumulation in the coronary arteries. V3D-Vascular is breakthrough software that permits rapid segmentation and visualization of complex arterial structures using 3D volume rendering, maximum intensity projection and simulated x-ray views. Viatronix, through application of the V3D technology, is developing additional innovative products that will be useful in early detection of other diseases, treatment planning, intervention and follow up evaluation. Viatronix, Inc. is located in Stony Brook, NY. For further information, call toll free 1-866-887-4636 or log on to http://www.viatronix.com .

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.

CONTACT: Jeannette Keels of Viatronix Inc., +1-631-444-6326,jkeels@viatronix.com

Web site: http://www.viatronix.com/